search

Active clinical trials for "Heart Diseases"

Results 2041-2050 of 3529

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies,...

Rheumatic Heart Disease

This program is a comprehensive evaluation of rheumatic valvular heart disease (RVHD), Atrial fibrillation (AF)/flutter and stroke. A prospective, randomized, parallel group, open-label clinical trial of rivaroxaban versus standard vitamin K antagonists (VKA) therapy to evaluate non-inferiority of rivaroxaban to VKA, with testing for superiority if non-inferiority is satisfied.

Completed27 enrollment criteria

Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease...

Liver DiseaseCardiovascular Disease

Background: It is still difficult to predict the outcome in patients requiring Fontan Revisions and in those who have evidence of congestive hepatopathy and probable cirrhosis requiring major cardiac surgery including heart transplant. Over the years, many prognostic indices have been derived from laboratory results of blood tests, clinical and physiological variables (or some combination thereof), from liver imaging to liver histology, which has issues of sampling error, medical risks and technical difficulty. None of these have proved entirely satisfactory. Predicting morbidity or survival is particularly important when deciding about Fontan revisions versus the need for heart transplantation. What is needed here is a truly reliable test of liver function that can help predict outcome, on the basis of a single measurement within few days of a planned revision. For this purpose, it is desirable that the chosen tests of liver performance be safe, non-invasive, easy to perform, have a rapid turnaround for results, and be readily repeatable. Tests of hepatic elimination of various exogenous substances have been described, such as galactose elimination capacity (GEC), indocyanine green (ICG) clearance, lidocaine metabolism to monoethylglycinexylidide (MEGX), and other tests that rely on liver metabolic capacity. None of these metabolic or clearance tests achieved widespread acceptance or use, mostly because their performance and analyses were cumbersome. HepQuant,LLC has developed a platform of tests of liver function which include Systemic Hepatic Filtration Rate (HFR), Portal HFR, SHUNT, and Disease Severity Index (DSI)1,2. HepQuant tests specifically target the hepatic uptake of cholate and use a single noninvasive test of 90 minutes duration to quantify the systemic circulation, portal circulation, and portal-systemic shunt and to derive a DSI in intact human subjects. HepQuant tests can assess all stages and etiologies of liver disease. In chronic HCV patients HepQuant testing can predict which patients will respond to antiviral therapy and can measure the improvement in hepatic function that occurs after successful antiviral therapy. Patients who did not respond were followed for an average of 5 years and up to 8 years, and baseline HepQuant testing could predict clinical outcomes (CTP progression, variceal bleeding, encephalopathy, ascites, liver-related death) with 87% sensitivity and 71% specificity.

Completed6 enrollment criteria

Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval...

Cardiovascular Events

The purpose of the study is to verfiy the hypothesis if a short intensive psychocardiological interval-intervention, combined with a structured follow up, decreases the rate of disability retirements caused by psychosocial co-morbidity of patients with coronary heart disease.

Unknown status11 enrollment criteria

Conventional Verses Ultrasound Guided Arteria Cannulation, With and Without Local Anesthesia

Heart Disease

The aim of the project is to compare two methods for arterial cannulation. The traditional method with ultrasound guided cannulation. The investigators goal is to improve this procedure to reduce pain and complications.

Completed5 enrollment criteria

Preventing American Indian Children From Becoming Overweight

Cardiovascular DiseasesHeart Diseases1 more

The purpose of this study is to establish an intervention to keep American Indian/Alaskan Native (AI/AN) children from becoming overweight.

Completed4 enrollment criteria

Establish Finite Element Mesh of the Numerical Models of the Thoracic Aorta

Heart Diseases

This study will be using finite element meshes and averaged algorithms to create the numerical thoracic aorta at different ages.

Completed1 enrollment criteria

Patterns of Coronary Artery Anatomy in Children With Congenital Heart Disease by Computed Tomography...

Heart Diseases

To test the ability of electron beam CT in evalting the coronary artery pattern in children with congenital heart disease.

Completed2 enrollment criteria

Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest

Cardiovascular DiseasesMyocardial Infarction4 more

To compare home use of an automatic external defibrillator (AED) to the use of local emergency medical system in treating survivors of sudden cardiac arrest.

Completed5 enrollment criteria

Education and Counseling for Abstinence From Tobacco After Pregnancy

Cardiovascular DiseasesHeart Diseases

The purpose of this study is to develop and field test a maintenance of smoking abstinence program designed for a predominately low-income, high-risk population of women from a wide variety of ethnic and racial backgrounds who have quit smoking because of (or during) their pregnancy.

Completed3 enrollment criteria

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Cardiovascular DiseasesCoronary Arteriosclerosis4 more

To assess whether hormonal replacement therapy and/or antioxidant treatment would stabilize or inhibit progression, and induce regression of coronary plaques. The mechanisms by which these treatments modified atherosclerosis in women were also explored.

Completed1 enrollment criteria
1...204205206...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs